Please wait a minute...
文章检索
预防医学  2018, Vol. 30 Issue (9): 874-878    DOI: 10.19485/j.cnki.issn2096-5087.2018.09.003
  论著 本期目录 | 过刊浏览 | 高级检索 |
艾滋病合并血流感染病原体种类及耐药分析
杨宗兴1,叶荣夏2,闫俊1,师金川1,朱明利1,喻剑华1
1.杭州市西溪医院,浙江 杭州 310023;
2.浙江省中医院下沙院区
Analysis of types and antimicrobial susceptibility of pathogens in AIDS patients with bloodstream infection
YANG Zong-xing*,YE Rong-xia,YAN Jun,SHI Jin-chuan,ZHU Ming-li,YU Jian-hua
*Xixi Hospital of Hangzhou,Hangzhou,Zhejiang 310023,China
全文: PDF(659 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解艾滋病合并血流感染患者的病原体种类及耐药性。方法 收集2012—2015年在杭州市西溪医院住院治疗的94例艾滋病合并血流感染患者的临床资料,对其血培养分离的病原体种类和耐药情况进行描述性分析。结果 94例患者共分离出菌株109株,其中分枝杆菌4株,占3.67%;革兰阳性菌45株,占41.29%,以表皮葡萄球菌最多(10.09%);革兰阴性菌34株,占31.19%,以大肠埃希菌最多(7.34%);真菌26株,占23.85%,包括马尔尼菲蓝状菌(13.76%)和新型隐球菌(10.09%)。革兰阳性菌对喹奴普汀/达福普汀、利奈唑胺、万古霉素、替加环素和呋喃妥因的耐药率均为0.00%,对莫西沙星耐药率为2.44%;革兰阴性菌对哌拉西林/他唑巴坦、厄他培南和亚胺培南3种药物的耐药率均为8.70%。结论 艾滋病合并血流感染患者病原体包括一定的机会感染病原体,对常用的三线抗菌药物敏感性较高。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
杨宗兴,叶荣夏,闫俊,师金川,朱明利,喻剑华
关键词 艾滋病血流感染败血症病原体    
AbstractObjective To investigate the types and antimicrobial susceptibility of pathogens in AIDS patients with bloodstream infection. Methods Demographic and clinical data of ninety four AIDS patients with bloodstream infection hospitalized in our hospital between 2012 and 2015 were collected. Descriptive analysis was conducted to investigate the types and antimicrobial susceptibility of pathogens of bloodstream infection. Results A total of 109 strains were isolated,including 4 strains of mycobacteria(3.67%),45 strains of gram positive bacteria(41.29%)with Staphylococcus epidermidis ranking first (10.09%),34 gram negative bacteria (31.19%)with Escherichia coli ranking first(7.34%),26 strains of fungi (23.85%),including Talaromyces marneffei(13.76%)and Cryptococcus neoformans(10.09%). In gram positive bacteria,zero resistance was observed in quinupristin/Dafoe leptin,linezolid,tigecycline,vancomycin,and nitrofurantoin,and the resistance rate was 2.44% with moxifloxacin. In gram negative bacteria,the same drug resistance rate of 8.70% was observed in piperacillin/tazobactam,imipenem and ertapene,respectively. Conclusion In AIDS patients with bloodstream infections,strains include certain opportunistic pathogens,mainly fungi . The pathogens are highly sensitive to the three commonly used line antimicrobial agents .
Key wordsAIDS    Bloodstream infection    Sepsis    Pathogen
          出版日期: 2018-09-04
中图分类号:  R512.91  
基金资助:浙江省医药卫生科技计划项目(2015KYB321);杭州市科技厅科技发展计划项目(20150733Q50);杭州市社会发展项目(20160533B54)
通信作者: 喻剑华,E-mail:yujhmc@126.com   
作者简介: 杨宗兴,博士,医师,主要从事艾滋病临床及科研工作
引用本文:   
杨宗兴,叶荣夏,闫俊,师金川,朱明利,喻剑华. 艾滋病合并血流感染病原体种类及耐药分析[J]. 预防医学, 2018, 30(9): 874-878.
YANG Zong-xing,YE Rong-xia,YAN Jun,SHI Jin-chuan,ZHU Ming-li,YU Jian-hua. Analysis of types and antimicrobial susceptibility of pathogens in AIDS patients with bloodstream infection. Preventive Medicine, 2018, 30(9): 874-878.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2018.09.003      或      http://www.zjyfyxzz.com/CN/Y2018/V30/I9/874
[1] HUSON M,STOLP S,VAN DER POLL T,et al. Community-acquired bacterial bloodstream infections in HIV-infected patients:a systematic review[J] . Clin Infect Dis,2014,58(1):79-92.
[2] 赵贺红,冯萍,肖贵宝,等. 艾滋病合并机会性感染的临床特征和诊疗分析[J] . 华西医学,2011,26(10):1496-1500.
[3] 朱晓红. 艾滋病患者合并机会性感染的临床特点和预后分析[J] . 中国继续医学教育,2017,9(17):106-107.
[4] TARAMASSO L,TATARELLI P,DI BIAGIO A. Bloodstream infections in HIV-infected patients[J] . Virulence,2016,7(3):320-328.
[5] 杨宗兴,吴南屏. 艾滋病患者血流感染的研究[J] . 国际流行病学传染病学杂志,2012,39(2):129-133.
[6] 中华医学会感染病学分会艾滋病学组. 艾滋病诊疗指南(2011版) [J] . 中华传染病杂志,2011,29(10):321-330.
[7] 中华医学会检验医学分会. 临床微生物学血培养操作规范[J] . 中华检验医学杂志,2004,27(2):124-126.
[8] 陆永绥,张伟民. 临床检验管理与技术规程(第二版) [M] . 杭州:浙江大学出版社,2014.
[9] PHE T,VLIEGHE E,REID T,et al. Does HIV status affect the aetiology,bacterial resistance patterns and recommended empiric antibiotic treatment in adult patients with bloodstream infection in Cambodia?[J] . Trop Med Int Health,2013,18(4):485-494.
[10] HARBOE Z,LARSEN M,LADELUND S,et al. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy:persistent high risk among HIV-infected injecting drug users[J] . Clin Infect Dis,2014,59(8):1168-1176.
[11] 许世申,陈国伟. 艾滋病合并败血症52例临床特点和病原菌分析[J] . 北方药学,2015,12(5):165-166.
[12] ZHENG J,GUI X,CAO Q,et al. A clinical study of acquired immunodeficiency syndrome associated penicillium marneffei infection from a non-endemic area in China[J] . PLoS ONE,2015,10(6):e0130376.
[13] 赵敬焕,刘迪,李亭,等. 血流感染患者的病原菌分析[J] . 中国感染与化疗杂志,2012,12(5):384-389.
[14] JACOB S T,PAVLINAC P B,NAKIYINGI L,et al. Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda-high frequency,low clinical suspicion [corrected] and derivation of a clinical prediction score[J] . PLoS ONE,2013,8(8):e70305.
[15] KIERTIBURANAKUL S,WATCHARATIPAGORN S,CHONGTRAKOOL P,et al. Epidemiology of bloodstream infections and predictive factors of mortality among HIV-infected adult patients in Thailand in the era of highly active antiretroviral therapy[J] . Japanese Journal of Infectious Diseases,2012,65(1):28.
[16] CRUMP J A,RAMADHANI H O,MORRISSEY A B,et al. Bacteremic disseminated tuberculosis in Sub-Saharan Africa:a prospective cohort study[J] . Clinical Infectious Diseases,2012, 55(2):242-250.
[17] BEDELL R A,ANDERSON S T,VAN L M,et al. High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi[J] . PLoS ONE,2012,7(6):e39347.
[18] 孙炜,叶米,汪霞梅,等. 肺结核患者与艾滋病病毒感染者双向筛检效果分析[J] . 预防医学,2016,28(3):259-261.
[19] 浙江省卫生和计划生育委员会.关于加强抗菌药物临床应用分级管理工作的通知[Z] . 2016.
[20] 周美儿,叶玲,王玲露,等. 某县级中医院医院感染资料分析[J] . 预防医学,2018,30(5):485-489.
[21] 贾磊,余运贤,陆锦琪,等. 某医院耐碳青霉烯类肠杆菌科细菌分布特征分析[J] . 浙江预防医学,2017,29(8):799-800.
[1] 俞素芬, 蒋青林, 戴杰. 2012—2021年吴兴区新报告HIV/AIDS病例晚发现及影响因素分析[J]. 预防医学, 2023, 35(9): 796-799.
[2] 郑伟, 张世勇, 杨纶砥, 熊华利. 基于年龄-时期-队列模型的1990—2019年我国艾滋病发病率趋势分析[J]. 预防医学, 2023, 35(8): 665-668,681.
[3] 王婷婷, 汪剡灵, 李桂霞, 常玥. 2012—2021年台州市新报告HIV/AIDS病例首次CD4+T淋巴细胞检测结果分析[J]. 预防医学, 2023, 35(7): 578-582.
[4] 姜海波, 洪航, 周健, 李继革, 史宏博, 谭诗文, 褚堃, 张丹丹. 宁波市HIV/AIDS病例新型毒品使用情况调查[J]. 预防医学, 2023, 35(6): 470-474.
[5] 柏建芸, 赵芳凝, 候金余, 郭燕, 郑敏娜, 李龙, 于茂河. 2005—2021年天津市医疗机构HIV/AIDS检测发现情况分析[J]. 预防医学, 2023, 35(6): 475-479.
[6] 徐亚华, 吴斌. 兰溪市120例HIV抗体筛查阳性样本确证结果分析[J]. 预防医学, 2023, 35(6): 538-540.
[7] 蔺茂文, 刘锐, 张凡, 李舒超, 刘建昭, 豆智慧, 孙春. 1996—2021年荆州市HIV/AIDS病例1年死亡分析[J]. 预防医学, 2023, 35(5): 396-400.
[8] 景正伟, 宁艳, 常文辉, 周超, 任强, 董丽芳, 贾华, 许诗瑶, 王志锋. 高校MSM人群HIV感染学生生存质量分析[J]. 预防医学, 2023, 35(4): 291-294.
[9] 许太彬, 程春荣, 段江洋, 兰培利, 段欣洋. 郑州市50岁及以上HIV/AIDS病例流行特征[J]. 预防医学, 2023, 35(4): 323-326.
[10] 陈银炜, 周洋, 刘珍, 张晓辉. 流动人口HIV感染孕产妇健康综合评价指标体系研究[J]. 预防医学, 2023, 35(3): 210-214.
[11] 蒋均, 陈军仙, 楼莲娟, 朱碧香, 查琏琦, 阮建军. 义乌市2016—2020年报告HIV/AIDS病例流动特征分析[J]. 预防医学, 2023, 35(1): 21-26.
[12] 张鹤美, 高四海, 陈向阳, 叶振淼, 李君, 赵丽娜, 苏德华, 胡文雪, 赖江宜, 陈婉君. 2006—2020年温州市新报告50岁及以上HIV/AIDS病例时空特征分析[J]. 预防医学, 2022, 34(5): 483-486.
[13] 张丽, 姚英, 胡锦峰, 潘忠廉. 上城区艾滋病自愿咨询检测门诊求询者特征及HIV感染情况分析[J]. 预防医学, 2022, 34(2): 161-165.
[14] 何丁玲, 冯世平, 赵霞, 郭利华, 吕春容, 李虹霞, 郭慧, 黄蕾. 艾滋病住院患者焦虑和抑郁情况调查[J]. 预防医学, 2022, 34(2): 166-170,175.
[15] 梁若枫, 周黎, 陈金花, 韩俊. 杭州市某高校大学生艾滋病防治知识、态度、行为调查[J]. 预防医学, 2022, 34(2): 208-212.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed